In recent ESC guidelines for the diagnosis and management of chronic coronary syndromes (CCS), ACE inhibitors are recommended for event prevention if a patient has other comorbid conditions (e.g., heart failure, hypertension, or diabetes) and should be considered in CCS patients at very high risk of cardiovascular events [46]. The gene discussed is ACE; the disease is Hypertension.